{"entity":{"type":"insider","cik":"0001640447","url":"/insider/0001640447","json_url":"/insider/0001640447.json","name":"Neylan John F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":32,"first":"2015-08-14","last":"2021-12-21","span_basis":"filed_date"},"name_variants":[{"name":"Neylan John F.","source":"filing","n_filings":32,"first_seen":"2015-08-14","last_seen":"2021-12-21"}],"transactions":[{"id":4531445,"accession":"0001601485-21-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000091","line_url":"/filing/0001601485-21-000091#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":2.6201,"price_display":"2.62","price_state":"stated","total_value":937.9958,"total_display":"938.00","shares_owned_after":35136.0,"shares_owned_after_display":"35,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-21","scope":"insider"},{"id":4833198,"accession":"0001601485-21-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000077","line_url":"/filing/0001601485-21-000077#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":374.0,"shares_display":"374","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":1544.62,"total_display":"1,544.62","shares_owned_after":35494.0,"shares_owned_after_display":"35,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":4109946,"accession":"0001601485-21-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000062","line_url":"/filing/0001601485-21-000062#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":373.0,"shares_display":"373","price_per_share":8.62,"price_display":"8.62","price_state":"stated","total_value":3215.26,"total_display":"3,215.26","shares_owned_after":35868.0,"shares_owned_after_display":"35,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider"},{"id":5418783,"accession":"0001601485-21-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000058","line_url":"/filing/0001601485-21-000058#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":376.0,"shares_display":"376","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":3786.32,"total_display":"3,786.32","shares_owned_after":36241.0,"shares_owned_after_display":"36,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-21","scope":"insider"},{"id":5418779,"accession":"0001601485-21-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000052","line_url":"/filing/0001601485-21-000052#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":381.0,"shares_display":"381","price_per_share":9.03,"price_display":"9.03","price_state":"stated","total_value":3440.43,"total_display":"3,440.43","shares_owned_after":36617.0,"shares_owned_after_display":"36,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":4489299,"accession":"0001601485-21-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000038","line_url":"/filing/0001601485-21-000038#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365.0,"shares_display":"365","price_per_share":10.98,"price_display":"10.98","price_state":"stated","total_value":4007.7,"total_display":"4,007.70","shares_owned_after":36998.0,"shares_owned_after_display":"36,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-22","scope":"insider"},{"id":5338373,"accession":"0001601485-21-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000029","line_url":"/filing/0001601485-21-000029#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366.0,"shares_display":"366","price_per_share":13.2,"price_display":"13.20","price_state":"stated","total_value":4831.2,"total_display":"4,831.20","shares_owned_after":37363.0,"shares_owned_after_display":"37,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":5532507,"accession":"0001601485-21-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000025","line_url":"/filing/0001601485-21-000025#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363.0,"shares_display":"363","price_per_share":13.91,"price_display":"13.91","price_state":"stated","total_value":5049.33,"total_display":"5,049.33","shares_owned_after":37729.0,"shares_owned_after_display":"37,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-19","scope":"insider"},{"id":5504303,"accession":"0001601485-21-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000013","line_url":"/filing/0001601485-21-000013#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":381.0,"shares_display":"381","price_per_share":13.55,"price_display":"13.55","price_state":"stated","total_value":5162.55,"total_display":"5,162.55","shares_owned_after":38092.0,"shares_owned_after_display":"38,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-20","scope":"insider"},{"id":5496772,"accession":"0001567619-21-006685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-006685","line_url":"/filing/0001567619-21-006685#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442.0,"shares_display":"442","price_per_share":19.13,"price_display":"19.13","price_state":"stated","total_value":8455.46,"total_display":"8,455.46","shares_owned_after":38453.0,"shares_owned_after_display":"38,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-19","scope":"insider"},{"id":6333347,"accession":"0001114220-18-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000110","line_url":"/filing/0001114220-18-000110#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1156.0,"shares_display":"1,156","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":3202.12,"total_display":"3,202.12","shares_owned_after":148279.0,"shares_owned_after_display":"148,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider"},{"id":6413702,"accession":"0001114220-18-000100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000100","line_url":"/filing/0001114220-18-000100#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1253.0,"shares_display":"1,253","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":3846.71,"total_display":"3,846.71","shares_owned_after":149435.0,"shares_owned_after_display":"149,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-29","filed_date":"2018-10-30","scope":"insider"},{"id":6863683,"accession":"0001114220-18-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000093","line_url":"/filing/0001114220-18-000093#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1186.0,"shares_display":"1,186","price_per_share":3.04,"price_display":"3.04","price_state":"stated","total_value":3605.44,"total_display":"3,605.44","shares_owned_after":150688.0,"shares_owned_after_display":"150,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-16","scope":"insider"},{"id":6541341,"accession":"0001114220-18-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000086","line_url":"/filing/0001114220-18-000086#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1282.0,"shares_display":"1,282","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":4948.52,"total_display":"4,948.52","shares_owned_after":151874.0,"shares_owned_after_display":"151,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-07-31","scope":"insider"},{"id":6093254,"accession":"0001114220-18-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000055","line_url":"/filing/0001114220-18-000055#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1158.0,"shares_display":"1,158","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":6589.02,"total_display":"6,589.02","shares_owned_after":153156.0,"shares_owned_after_display":"153,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":6520547,"accession":"0001114220-18-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000046","line_url":"/filing/0001114220-18-000046#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1311.0,"shares_display":"1,311","price_per_share":4.67,"price_display":"4.67","price_state":"stated","total_value":6122.37,"total_display":"6,122.37","shares_owned_after":154314.0,"shares_owned_after_display":"154,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-30","filed_date":"2018-05-01","scope":"insider"},{"id":6605776,"accession":"0001114220-18-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000041","line_url":"/filing/0001114220-18-000041#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1111.0,"shares_display":"1,111","price_per_share":4.59,"price_display":"4.59","price_state":"stated","total_value":5099.49,"total_display":"5,099.49","shares_owned_after":155625.0,"shares_owned_after_display":"155,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-24","scope":"insider"},{"id":6681645,"accession":"0001114220-18-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000022","line_url":"/filing/0001114220-18-000022#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5652.0,"shares_display":"5,652","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":27186.12,"total_display":"27,186.12","shares_owned_after":115486.0,"shares_owned_after_display":"115,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":6622161,"accession":"0001114220-18-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000014","line_url":"/filing/0001114220-18-000014#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1541.0,"shares_display":"1,541","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":7412.21,"total_display":"7,412.21","shares_owned_after":121138.0,"shares_owned_after_display":"121,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-29","filed_date":"2018-01-31","scope":"insider"},{"id":6257101,"accession":"0001114220-18-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000008","line_url":"/filing/0001114220-18-000008#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1322.0,"shares_display":"1,322","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":6504.24,"total_display":"6,504.24","shares_owned_after":122679.0,"shares_owned_after_display":"122,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-24","scope":"insider"},{"id":4164310,"accession":"0001114220-17-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000042","line_url":"/filing/0001114220-17-000042#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":8472.15,"total_display":"8,472.15","shares_owned_after":124001.0,"shares_owned_after_display":"124,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-10-31","scope":"insider"},{"id":5167902,"accession":"0001114220-17-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000034","line_url":"/filing/0001114220-17-000034#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1179.0,"shares_display":"1,179","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":7698.87,"total_display":"7,698.87","shares_owned_after":125406.0,"shares_owned_after_display":"125,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-24","scope":"insider"},{"id":4983749,"accession":"0001114220-17-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000020","line_url":"/filing/0001114220-17-000020#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":7.14,"price_display":"7.14","price_state":"stated","total_value":10317.3,"total_display":"10,317.30","shares_owned_after":126585.0,"shares_owned_after_display":"126,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-01","scope":"insider"},{"id":4448520,"accession":"0001114220-17-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000013","line_url":"/filing/0001114220-17-000013#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1214.0,"shares_display":"1,214","price_per_share":7.27,"price_display":"7.27","price_state":"stated","total_value":8825.78,"total_display":"8,825.78","shares_owned_after":128030.0,"shares_owned_after_display":"128,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-24","filed_date":"2017-07-25","scope":"insider"},{"id":4351334,"accession":"0000899243-17-011612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-011612","line_url":"/filing/0000899243-17-011612#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1441.0,"shares_display":"1,441","price_per_share":5.97,"price_display":"5.97","price_state":"stated","total_value":8602.77,"total_display":"8,602.77","shares_owned_after":129244.0,"shares_owned_after_display":"129,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":5196374,"accession":"0000899243-17-010904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-010904","line_url":"/filing/0000899243-17-010904#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1209.0,"shares_display":"1,209","price_per_share":5.73,"price_display":"5.73","price_state":"stated","total_value":6927.57,"total_display":"6,927.57","shares_owned_after":130685.0,"shares_owned_after_display":"130,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-26","scope":"insider"},{"id":4331817,"accession":"0000899243-17-002275","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-002275","line_url":"/filing/0000899243-17-002275#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6984.0,"shares_display":"6,984","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":32475.6,"total_display":"32,475.60","shares_owned_after":83144.0,"shares_owned_after_display":"83,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-30","filed_date":"2017-01-31","scope":"insider"},{"id":5305459,"accession":"0000899243-17-001941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-001941","line_url":"/filing/0000899243-17-001941#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1428.0,"shares_display":"1,428","price_per_share":5.39,"price_display":"5.39","price_state":"stated","total_value":7696.92,"total_display":"7,696.92","shares_owned_after":90128.0,"shares_owned_after_display":"90,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-23","filed_date":"2017-01-25","scope":"insider"},{"id":2501763,"accession":"0000899243-16-032270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-032270","line_url":"/filing/0000899243-16-032270#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1211.0,"shares_display":"1,211","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":5715.92,"total_display":"5,715.92","shares_owned_after":91556.0,"shares_owned_after_display":"91,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-24","filed_date":"2016-10-25","scope":"insider"},{"id":2350096,"accession":"0000899243-16-025770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-025770","line_url":"/filing/0000899243-16-025770#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1217.0,"shares_display":"1,217","price_per_share":7.43,"price_display":"7.43","price_state":"stated","total_value":9042.31,"total_display":"9,042.31","shares_owned_after":92767.0,"shares_owned_after_display":"92,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-25","filed_date":"2016-07-27","scope":"insider"},{"id":3273899,"accession":"0000899243-16-018630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-018630","line_url":"/filing/0000899243-16-018630#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4766.0,"shares_display":"4,766","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":24830.86,"total_display":"24,830.86","shares_owned_after":93984.0,"shares_owned_after_display":"93,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":8437049,"accession":"0000899243-15-003121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-003121","line_url":"/filing/0000899243-15-003121#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001640447","owner_name":"Neylan John F.","owner_url":"/insider/0001640447","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":62000.0,"total_display":"62,000.00","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601485","name":"Angion Biomedica Corp.","url":"/issuer/0001601485","role":"Officer","n_filings":10,"first_seen":"2021-03-19","last_seen":"2021-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Officer (Chief Medical Officer)","n_filings":22,"first_seen":"2015-08-14","last_seen":"2018-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001640447","retrieved_at":"2026-08-21T18:35:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}